Back to Database
Status published
High
CVE-2007-6763
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which...
Vulnerability Description
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
Impact Analysis
Refer to official advisory for detailed impact metrics.
Remediation
Ensure systems are updated to the latest vendor-supplied patch levels.
THREAT MONITOR
Am I Vulnerable?
Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2007-6763
Credits & Attribution
No credits recorded in the NVD database.
More from sas
View All →CVE-2022-25256
SAS Web Report Studio 4.4 allows XSS. /SASWebReportStudio/logonAndRender.do has two...
Medium
6.1
CVE-2021-41569
SAS/Intrnet 9.4 build 1520 and earlier allows Local File Inclusion....
High
7.5
CVE-2021-35475
SAS Environment Manager 2.5 allows XSS through the Name field...
Medium
5.4
CVE-2020-9350
Graph Builder in SAS Visual Analytics 8.5 allows XSS via...
Medium
5.4
CVE-2019-14678
SAS XML Mapper 9.45 has an XML External Entity (XXE)...
Critical
10
Affected Vendor
Affected Software
sas drug development
Vulnerable Versions:
0
Timeline
Official Publish:
July 31st, 2019
Last Modified:
August 7th, 2024
Added to House:
July 18th, 2026
CVSS Vectors
V3:
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weaknesses (CWE)
No CWE data available
MITRE ATT&CK TTPs
No associated TTPs found for this vulnerability.